The Expansión-Allfunds awards brought together the collective investment sector on Tuesday to recognise the best funds and pension plans of 2021. In this thirty-third edition, the newspaper’s readers have awarded Laboratorios Farmacéuticos ROVI with the Salmón Award for the best stock market value of the year, highlighting the exceptional stock market performance experienced last year, with a revaluation of 96%.
The award was collected by Javier López Belmonte, Vice President and CFO of ROVI, who highlighted the great effort made in 2021, both for the manufacture of millions of doses to combat the pandemic and for having achieved approval in Europe of the first drug for schizophrenia based on the ISM platform. “All this effort has been rewarded by the market and we are deeply grateful for it. As you know, at the end of 2021 we will join the Ibex 35, reinforcing the presence of health sector companies in the index at a crucial time for society. The positive performance of the Laboratory’s shares on the stock market since then shows that ROVI is a solid company with a strong and solid future in which investors have confidence,” he said.
In her speech, Ana Isabel Pereda, director of Expansión, stressed the importance of responsible and professional management: “It is in situations of maximum market instability that professional management is most valuable. For this reason, these awards are Expansión’s recognition of the professionals who have to make important investment decisions in such difficult times as the present. Today’s award goes to ROVI in recognition of the immense work carried out by the pharmaceutical sector in the pandemic and, more specifically, for its direct involvement in the manufacture of the Moderna vaccine”.
